期刊文献+

冠状动脉内支架术后即刻明胶酶变化的研究

Changes of Gelatinase after Stent Implantation in Sigle-Vessel Disease Patients
下载PDF
导出
摘要 目的:探讨在急性心肌梗塞患者冠状动脉支架术后(PTCA)明胶酶的变化;方法:15例确诊为单支血管病变的急性心肌梗塞患者,在PTCA术前及术后5分钟内冠状动脉窦内取抗凝血2ml,利用Gelatin-PAGE法测冠状动脉内明胶酶的活性表达;结果:在术后明胶酶A比术前高(P<0.05),明胶酶B与术前无明显变化(P>0.05)。结论:明胶酶可能参与支架术后再狭窄过程。 AIM:To investigate the changes of gelatinase after stent implantation in sigle vessel disease patiens. METHODS: The activity of gelatinaseA and gelatinase B in coronary blood are detected by zymagraphy in 15 acute myocardial infartion who are sigle vessel disease patiens before and after stent implatation (befor PTCA and after PTCA) ;RESULT :The indexes of the expression of gelatinaseA after PTCA were higher than those before PTCA , P 〈0. 05 ; the indexes of gelatinase B have no different between before PTCA and after PTCA (P〉0.05). CONCLUSION: Gelatinase maybe participate the restonis after stent implantation.
出处 《中国分子心脏病学杂志》 CAS 2003年第1期18-20,共3页 Molecular Cardiology of China
关键词 PTCA 明胶酶 心肌梗塞 Gelatinase PTCA acute myocardial infartion
  • 相关文献

参考文献10

  • 1[1]Feldman LJ, Agurre L, Ziol M, et al. Interleukin-10 inhibite inhibts intimal hyperplasia after angioplasty or stent implantation in hypercholesterolemic rabbits. Circulation. 2000; 101:908-916.
  • 2[2]Farb A, Sangiorgi G, Carter AJ, et al. Pathology of acute and chronic coronary stenting in humans. Circulation. 1999; 99:44-52.
  • 3[3]Forsyth PA, Wong H, Liang TD, er al. Gelatinase A(MMP-2), Gelatinase B(MMP-9), and membrane type matrix metalloproteinases 1(MT1-MMP) are involed in different aspects of the pathophysiology of malignant gliomas. Britsh Jounal of Cancer. 1999,79(11/12): 1828-1835.
  • 4[4]Spinal FG, Coker ML, Henng LJ, etal. A matrix metallopro-teinasesinduction/activation system exists in the human left ventricular myocardium and is upregulated in heart failure. Circulation. 2000 OCT 17; 102(16): 1944-1953.
  • 5[5]Peterson JT, Li H, Dillon L,et al. Evolution of matrix metallo-proteinases and tissue inhibitor expression during heart failure progression in the infracted rat. Cardiovasc-Res. 2000 May; 46 (2):307-315.
  • 6[6]Pasterkamp G, Schoneveld AH, Hijnen DJ, er al. Atherosclerotic arterial remodeling ang the localization of macrophages and matrix metalloproteinases 1,2 and 9 in human coronary artery.Atherosclerosis. 2000 JUN; 150(2) :245-253.
  • 7[7]Dollery CM, Mcewan JR, Henney AM. Matrix metalloproteinases and cardiovascular disease. Circulation Research. 1995;77(5) :863-868.
  • 8[8]Aimes RT, Quigley JP. Matrix metalloproteinases-2 is an interstitial collagenase inhibitor-free enzyme catalyzes the cleavage of collagen fibrils and soluble native type Ⅰ collagen generating the specific 3/4-and 1/4-length fragments. J Biol Chem. 1995;270: 5872-5876.
  • 9[9]Laurent J, Feldman MD, Mikael Mazibhi, et al. Differential expression of matrix metalloproteinase after stent implantation and balloon angioplasty in the hypercholesterolemic rabbit. Circulation. 2001; 103:3117-3122.
  • 10[11]Nagase H,Woessner JF Jr.Matrix metalloproteinases.J Biol.Chem.1999;274:21491-21494.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部